CLINICAL_TRIALS
trial_result
· 2024-09-24
Clinical Trial Update: Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men. [Phase 1]
Summary
Phase 1 safety and tolerability study of RN564 in women with osteopenia and healthy men has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Osteopenia, Osteoporosis | Phase 1 | Status: COMPLETED | Results posted: 2024-09-24